HCPCS Level IIdrugActive
J3397
Inj., vestronidase alfa-vjbk
BETOS: O1E
Effective: 2024-01-01
Description
Injection, vestronidase alfa-vjbk, 1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Mepsevii
Manufacturer
Ultragenyx Pharmaceutical Inc.
HCPCS Dosage
1 MG
Billing Units
10.0000
1
NDC Products
opps
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.